Document is current
Any future updates will be listed below
-
Authors
Dierick, Herlinde http://orcid.org/0000-0002-8558-2569
Navarro, Laurent
Ceuppens, Hannelore
Ertveldt, Thomas
Pombo Antunes, Ana Rita
Keyaerts, Marleen
Devoogdt, Nick
Breckpot, Karine
D’Huyvetter, Matthias
Lahoutte, Tony
Caveliers, Vicky
Bridoux, Jessica
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (I001618N, I005622N, 1S06622N, 1230824N, 1801619N, 12H3619N)
Vrije Universiteit Brussel (SRP50, SRP95, SRP62, IOF3018, IOF3009)
Innoviris (2020-RDIR-1)
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 15 July 2024
First Online: 24 July 2024
Declarations
:
: The ethical committee for animal experiments at the Vrije Universiteit Brussel approved the in vivo study protocols (22-272-12 & 19-272-17). All mouse experiments were executed in accordance with the European guidelines for animal experimentation. Written informed consent was not required for this study.
: Not applicable.
: K.B., N.D., M.D., M.K., T.L and J.B. have patents on using sdAbs for imaging and therapy. M.K is an editor in EJNMMI. J.B is an unpaid board member of eSRR. T.L., N.D. and M.K. have ownership in AbScint. M.K. received research funding from Precirix. N.D. and M.D are resp. consultant and employee for and hold ownership in Precirix. L.N. and A.R.P.A. are employees of Precirix.
